Coherus Looks To Raise $200m Amid Coronavirus Impact

Comes As Firm Warns Of Possible COVID-19 Adversity

 
• By Dean Rudge
  
Dollars
Coherus will use some of the proceeds for pipeline acquisitions or licenses • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business